Somnair Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
2ndary - Private
- Investors
-
16
Somnair General Information
Description
Developer of a non-invasive neurostimulation device intended for the treatment of obstructive sleep apnea. The company's platform delivers therapy that targets the root neurological causes of airway obstruction without surgical intervention, is deployable in a home setting, enabling healthcare providers to access a potentially more accessible, patient-friendly alternative to traditional continuous positive airway pressure or implant-based therapies.
Contact Information
Website
www.somnairsleep.comCorporate Office
- 307 Washington Avenue
- Baltimore, MD 21204
- United States
Corporate Office
- 307 Washington Avenue
- Baltimore, MD 21204
- United States
Somnair Timeline
Somnair Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Secondary Transaction - Private | 31-Mar-2026 | Completed | Pre-Clinical Trials | |||
| 15. Seed Round | 07-Jul-2025 | Completed | Pre-Clinical Trials | |||
| 14. Accelerator/Incubator | 24-Jun-2025 | Completed | Pre-Clinical Trials | |||
| 13. Grant | 03-Jun-2025 | Completed | Pre-Clinical Trials | |||
| 12. Accelerator/Incubator | 30-Sep-2024 | Completed | Pre-Clinical Trials | |||
| 11. Grant | 08-Apr-2024 | Completed | Pre-Clinical Trials | |||
| 10. Grant | 16-Feb-2024 | Completed | Pre-Clinical Trials | |||
| 9. Accelerator/Incubator | 01-Jan-2024 | Completed | Pre-Clinical Trials | |||
| 8. Accelerator/Incubator | 26-Jul-2023 | $5K | $5K | Completed | Pre-Clinical Trials | |
| 7. Grant | 16-May-2023 | $5K | Completed | Pre-Clinical Trials |
Somnair Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Pre-Seed-1 | ||||||||
| Pre-Seed |
Somnair Patents
Somnair Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024301234-A1 | Methods and systems for treating sleep disordered breathing | Pending | 24-Jul-2023 | ||
| EP-4750523-A1 | Methods and systems for treating sleep disordered breathing | Pending | 24-Jul-2023 | ||
| WO-2025024561-A1 | Methods and systems for treating sleep disordered breathing | Inactive | 24-Jul-2023 | A61F5/566 |
Somnair Signals
Somnair Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HopStone Capital | Venture Capital | Minority | ||
| J2 Ventures | Venture Capital | Minority | ||
| Jumpspace Ventures | Venture Capital | Minority | ||
| MedStar Health | Corporation | Minority | ||
| Wolf Point Capital | Venture Capital | Minority |
Somnair FAQs
-
When was Somnair founded?
Somnair was founded in 2022.
-
Where is Somnair headquartered?
Somnair is headquartered in Baltimore, MD.
-
What is the size of Somnair?
Somnair has 6 total employees.
-
What industry is Somnair in?
Somnair’s primary industry is Therapeutic Devices.
-
Is Somnair a private or public company?
Somnair is a Private company.
-
What is Somnair’s current revenue?
The current revenue for Somnair is .
-
How much funding has Somnair raised over time?
Somnair has raised $4.33M.
-
Who are Somnair’s investors?
HopStone Capital, J2 Ventures, Jumpspace Ventures, MedStar Health, and Wolf Point Capital are 5 of 16 investors who have invested in Somnair.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process